Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/06/2021 → 31/12/2025 |
Funding
- EORTC European Organisation for Research and Treatment of Cancer: £198,217.92
A phase 1-2 study to identify which HRQoL issues need to be assessed for cancer patients on immune checkpoint inhibitors
- Van Hemelrijck, Mieke (Primary Investigator)
Project: Research